United States

People: AfroCentric Investment Corporation Ltd (ACTJ.J)

ACTJ.J on Johannesburg Stock Exchange

26 May 2017
Change (% chg)

22.00 (+3.72%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bisaro, Paul 

Mr. Paul M. Bisaro is a Director of the Company. He was Executive Chairman of the Board of Allergan Plc. Mr. Bisaro has served as Executive Chairman of our Board of Directors since July 2014. He previously served as our President and Chief Executive Officer and as Chairman of our Board of Directors beginning October 2013; prior to serving as Chairman he served on the Board of Directors beginning September 2007. Prior to joining the Company, Mr. Bisaro was President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company (“Barr”), from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr, and from 1997 to 1999, served in various additional capacities including Senior Vice President — Strategic Business Development. Prior to joining Barr, he was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds, from 1989 to 1992. Mr. Bisaro also currently serves on the Board of Visitors of the Catholic University of America’s Columbus School of Law and the Boards of Directors of Zimmer Biomet Holdings, Inc. and Zoetis, Inc. The Board of Directors concluded that Mr. Bisaro should serve on the Board of Directors because of his experience as a senior executive in our industry, his knowledge of our Company and its day-to-day operations and his strong strategic vision for the Company.

Basic Compensation

Total Annual Compensation, USD 18,725,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 237,918
Fiscal Year Total, USD 18,962,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --